Capecitabine 500mg Tablet, Film Coated
Product Images NDC 72485-205

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Capecitabine 500mg (NDC 72485-205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72485205 2

This is a description of Capecitabine tablets, USP which is a cytotoxic agent. Each film-coated tablet contains 500 mg capecitabine, USP. It is recommended to swallow the tablets as a whole and not to crush or cut them. It is advised to read the accompanying insert for dosage recommendations and other important prescribing information. The tablets should be dispensed in tight containers as defined in USP guidelines and should be stored at a temperature of 25°C (77°F), with permitted excursions to 15° to 30°C (59° to 86°F). The tablets are manufactured by Shilpa Medicare Limited, India and distributed by Armas Pharmaceuticals, Inc, in Manalapan, NJ, USA.*

FDA Label Image

Figure 1 Kaplan-meier Estimates Of Disease-free Survival (all Randomized Population)a (Fig 1)

FDA Label Image

Figure 2 Kaplan-meier Estimates Of Overall Survival (all Randomized Population) (Fig 2)

FDA Label Image

Figure 3 Kaplan-meier Curve For Overall Survival Of Pooled Data (studies 1 And 2) (Fig 3)

FDA Label Image

Figure 4 Kaplan-meier Estimates For Time To Disease Progression Capecitabine And Docetaxel Vs Docetaxel (Fig 4)

FDA Label Image

Figure 5 Kaplan-meier Estimates Of Survival Capecitabine And Docetaxel Vs Docetaxel (Fig 5)

This appears to be a chart or table showing estimated probabilities for different medication dosages and schedules. The medications listed are Docetaxel and Capecitabine, along with corresponding dosages in mg/sqm (milligrams per square meter) and frequency (e.g. every 3 weeks). Without additional context or information, it is not clear what the probabilities represent or how they were calculated.*

FDA Label Image

Metabolic Pathway (Meta Pathway)

FDA Label Image

Structural Formula (Structural Formula)

Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.